Purpose: A concept elicitation, cognitive debriefing, and usability study was undertaken to: 1) ascertain the migraine experience with a particular focus on the impact on roles and daily functioning; 2) determine the comprehensiveness and comprehensibility of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome Role Function-Restrictive (MSQ v2.1 ePRO RFR) domain items, and the appropriateness and understanding of the recall period, response options, and instructions; and 3) assess the usability on an electronic tablet device.
Methods: Eleven US English-speaking people with episodic or chronic migraine were recruited to participate in one-on-one interviews, encompassing methods appropriate for concept elicitation, cognitive debriefing, and usability testing. Interviews were audio-recorded, transcribed, and analyzed following the constant comparative method.
Results: Participants (seven episodic and four chronic) had a mean age of 34.8 years, and nine were female. Through spontaneous mention or probing, the concepts of the MSQ v2.1 ePRO RFR domain items were described and endorsed by all participants as day-to-day functioning restrictions; except for item 5 (ability to concentrate), which was endorsed by 10 of 11 participants. Cognitive interviewing confirmed the MSQ v2.1 ePRO instructions were clear, meaningful, and important to assess as daily functioning impacts experienced as a result of migraine. Overall impressions of the ePRO device were favorable, and no participants reported any difficulties with use.
Conclusions: The MSQ v2.1 ePRO RFR domain is content-valid and appropriate for inclusion in future studies designed to measure the functional impact of episodic or chronic migraine on the performance of day-to-day activities.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624220 | PMC |
http://dx.doi.org/10.1186/s41687-019-0138-x | DOI Listing |
BMJ Open
April 2024
Medical Affairs, Otsuka Pharmaceutical Co Ltd, Tokushima, Japan.
Objective: To describe the characteristics of patients who sought medical attention for headache and those who did not.
Design: This observational study used a cross-sectional online survey and linked medical claims data.
Setting: Data from an online self-administered questionnaire survey conducted in November 2020 as well as linked medical claims data spanning December 2017 and November 2020 were provided by DeSC Healthcare Inc.
Headache
November 2022
VA New York Harbor Healthcare System, New York, New York, USA.
Background: Stigma is increasingly recognized as an important social feature of living with migraine.
Methods: Adults with migraine recruited from neurology offices completed the validated Stigma Scale for Chronic Illnesses 8-item version (SSCI-8); two outcome measures (the Migraine Disability Assessment [MIDAS] and the Migraine-Specific Quality of Life Questionnaire v 2.1 [MSQ]); and measures of allodynia (Allodynia Symptom Checklist [ASC-12]), pain cognition (Pain Catastrophizing Scale [PCS]), and psychiatric symptoms (Patient Reported Measurement Information System Anxiety [PROMIS-A] and Depression [PROMIS-D]).
J Oral Facial Pain Headache
November 2017
Aims: To evaluate the validity of the Korean Migraine-Specific Quality of Life Questionnaire version 2.1 (K-MSQ v 2.1) in patients with episodic migraine (EM) or chronic migraine (CM).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!